Lyka Labs Ltd share price logo

Lyka Labs Ltd Share Price

(LYKALABS)

Small Cap

Healthcare Sector

₹113.17▲2.73%

as on 04:01PM, 25 Apr 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Lyka Labs Performance

  • Day's Low

    Day's High

    ₹110.22
    Day's Price Range
    ₹116.95

  • 52 Week's Low

    52 Week's High

    ₹96.8
    52-Week Price Range
    ₹176.59
1 Month Return+ 10.07 %
3 Month Return-19.83 %
1 Year Return-7.66 %
Previous Close₹116.35
Open₹116.55
Volume49.40K
Upper Circuit₹139.62
Lower Circuit₹93.08
Market Cap₹415.25Cr

Lyka Labs Fundamentals

P/E Ratio

-55.4

PEG Ratio

64.42

Market Cap

₹415.25 Cr

P/B Ratio

3.88

EPS

-0.79

Dividend Yield

0

Sector

Pharmaceuticals

ROE

0

Key events for Lyka Labs Ltd

  • Lyka Labs Patent Boosts Stock with 10% Surge - 08 Apr, 2025

    Lyka Labs Limited announced the grant of an Indian patent for Pregabalin Gel 8%, a topical solution for diabetic neuropathic pain, valid until 2043. Following this news, the stock surged by 10%, reflecting investor confidence in this innovative product's potential in pain management.

Insights on Lyka Labs Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Promoter Holding Up

    img

    Promoters have increased holdings from 58.10% to 58.16% in Mar 2025 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 4 quarters, -2.13 Cr → 2.71 Cr (in ₹), with an average increase of 100.6% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, LYKALABS stock has moved up by 4.4%

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.15% to 0.23% in Mar 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 61.7% return, outperforming this stock by 69.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 143.4% return, outperforming this stock by 179.0%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 41.08% to 40.94% in Mar 2025 quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 41.18 Cr → 34.62 Cr (in ₹), with an average decrease of 15.9% per quarter

Lyka Labs Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹32.56Cr (-)₹27.77Cr (↓14.71%)₹30.11Cr (↑8.43%)₹41.16Cr (↑36.70%)₹33.80Cr (↓17.88%)
Net Income₹1.78Cr (-)-₹2.13Cr (↓219.66%)₹1.44Cr (↓167.61%)₹2.10Cr (↑45.83%)₹2.71Cr (↑29.05%)
Net Profit Margin5.47% (-)-7.67% (↓240.22%)4.78% (↓162.32%)5.10% (↑6.69%)8.02% (↑57.25%)
Value in ₹ crore
Details2021202220232024
Total Assets₹213.37Cr (-)₹208.51Cr (↓2.28%)₹178.86Cr (↓14.22%)₹185.89Cr (↑3.93%)
Total Liabilities₹208.25Cr (-)₹163.29Cr (↓21.59%)₹101.35Cr (↓37.93%)₹85.48Cr (↓15.66%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow-₹11.45Cr (-)₹5.75Cr (↓150.22%)₹76.53Cr (↑1,230.96%)₹6.87Cr (↓91.02%)₹3.09Cr (↓55.02%)

Lyka Labs Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
58.16%
0.00
Foreign Institutions
0.23%
0.00
Mutual Funds
0.01%
0.00
Retail Investors
40.94%
0.00
Others
0.66%
0.00

Lyka Labs Key Indicators

Details20202021202220232024
Earning Per Share (₹)-21.83-3.5213.4-4.29-0.79
Details2022
Return On Equity %58.27
Details20202021202220232024
Return On Assets %-27.36-5.4118.7-7.39-1.34
Details20202021202220232024
Book Value Per Share (₹)-5-8.994.659.1217.86

Lyka Labs Valuation

Lyka Labs in the last 5 years

  • Overview

  • Trends

Lowest (-164.66x)

September 10, 2018

Today (-55.40x)

April 24, 2025

Industry (54.50x)

April 24, 2025

Highest (23.04x)

September 5, 2022

LowHigh

Lyka Labs Earnings and Dividends

  • Lyka Labs Ltd Earnings Results

    Lyka Labs Ltd’s net profit jumped 52.25% since last year same period to ₹2.71Cr in the Q3 2024-2025. On a quarterly growth basis, Lyka Labs Ltd has generated 29.05% jump in its net profits since last 3-months.

    Read More about Earnings Results

Lyka Labs Technicals Summary

Bearish

Neutral

Bullish

Neutral

Lyka Labs Ltd is currently in a Neutral trading position according to technical analysis indicators.

More on Technical Analysis

Lyka Labs Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Lyka Labs Ltd
Lyka Labs Ltd
NA₹415.25 Cr114.9%0.69-₹3 Cr₹111 Cr
Wockhardt Ltd
Wockhardt Ltd
NA₹23,807.39 Cr99.06%0.77-₹472 Cr₹2,798 Cr
Supriya Lifescience Ltd
Supriya Lifescience Ltd
BUY₹5,686.91 Cr16.16%0.50NANA
Wanbury Ltd
Wanbury Ltd
NA₹907.28 Cr222.86%0.91₹55 Cr₹575 Cr
Auro Laboratories Ltd
Auro Laboratories Ltd
NA₹155.78 Cr98.93%0.69NANA
See all

About Lyka Labs

Lyka Labs, a bulk drug company, has been in the business of offering lifesaving antibiotics and treating minor infections for over three decades. Over the years, the company has also diversified into marketing medical and diagnostic machinery and equipment, ayurvedic and animal health care products, tropical steroids, anticancer products, cardiovascular drugs, and anti-inflammatory products. In the year 1991 they received a Certificate of Merit for their impressive export performance and an award from CHEMEXCIL. Two years later, their Administrative Office and Plant at Tarapur was awarded the ISO 9002 certification for its quality management system. As part of its diversification, the company had also invested in Relic Finance and acquired 26.70% of the company's paid-up equity capital through a public offer. They also launched India's first Glutathione Injection formulation during 2012-13 to become one of India's leading healthcare and pharmaceutical companies.

Revenue: ₹33.80Cr as on December 2024 (Q4 24)
Net Profit: ₹2.71Cr as on December 2024 (Q4 24)
Listing date: 08 Feb, 1995
Chairperson Name: KUNAL NARENDRA GANDHI
OrganisationLyka Labs
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Lyka Labs Ltd

What is Lyka Labs Ltd price today?

Lyka Labs Ltd share price today stands at ₹113.17, Open: ₹116.55, Previous Close: ₹116.35, High: ₹116.95, Low: ₹110.22, 52 Week High: ₹176.59, 52 Week Low: ₹96.8.

How to Buy Lyka Labs Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Lyka Labs Ltd shares

What are today's traded volumes of Lyka Labs Ltd?

Today's traded volume of Lyka Labs Ltd(LYKALABS) is 49.40K.

What is today's market capitalisation of Lyka Labs Ltd?

Today's market capitalisation of Lyka Labs Ltd(LYKALABS) is ₹415.25Cr.

What is the 52 Week High and Low Range of Lyka Labs Ltd?

Lyka Labs Ltd (LYKALABS)
Price
52 Week High
₹176.59
52 Week Low
₹96.8

How much percentage Lyka Labs Ltd is down from its 52 Week High?

Lyka Labs Ltd (LYKALABS) share price is ₹113.17. It is down -35.91% from its 52 Week High price of ₹176.59

How much percentage Lyka Labs Ltd is up from its 52 Week low?

Lyka Labs Ltd (LYKALABS) share price is ₹113.17. It is up 16.91% from its 52 Week Low price of ₹96.8